Aug 2025 $231 M No. 6 $50 to $250 million 8
Capital Rx, Inc.: Raise no. 6, Aug 2025 × Investors in this round 8 investors had bought by the notice of Sep 26, 2025: 8 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $231 M of $233 M offered; $2 M still to sell
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice A. J. Loiacono · Executive Officer, Director Daniel J. Delmastro · Director Holly J. Maloney · Director Jared J. Kesselheim · Director Kevin J. Hill · Director Lenard J. Marcus · Director Mark J. Kandrysawtz · Director Mostafa J. Kamal · Director Robert J. Mittendorff · Director Ryan J. Kelly · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by A.J. Loiacono, Chief Executive Officer. Source: SEC Form D, newest notice filed Sep 26, 2025. Read the notice at the SEC .
equity SEC Mar 2024 $115 M No. 5 $50 to $250 million 1
Capital Rx, Inc.: Raise no. 5, Mar 2024 × Investors in this round 1 investor had bought by the notice of Mar 22, 2024: 1 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $115 M of $313 M offered; $198 M still to sell
Smallest investment taken no minimum stated
What was sold equity, options or other rights to buy securities Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice A. J. Loiacono · Director, Executive Officer Daniel J. Delmastro · Director Feby J. Abraham · Director Jared J. Kesselheim · Director Kevin J. Hill · Director Lenard J. Marcus · Director Robert J. Mittendorff · Director Ryan J. Kelly · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by A.J. Loiacono, Chief Executive Officer. Source: SEC Form D and 1 amendment, newest notice filed Mar 22, 2024. Read the notice at the SEC .
equity, options SEC May 2022 $106 M No. 4 $50 to $250 million 9
Capital Rx, Inc.: Raise no. 4, May 2022 × Investors in this round 9 investors had bought by the notice of Jun 13, 2022: 9 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $106 M of $106 M offered
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice A. J. Loiacono · Executive Officer, Director Joseph J. Alexander · Executive Officer Laleh J. Alemzadeh · Executive Officer · Secretary Jared J. Kesselheim · Director Kevin J. Hill · Director Lenard J. Marcus · Director Robert J. Mittendorff · Director · Appointed 5/27/2022 Ryan J. Kelly · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by A.J. Loiacono, Ceo. Source: SEC Form D, newest notice filed Jun 13, 2022. Read the notice at the SEC .
equity SEC Apr 2021 $3 M No. 3 $2 to $10 million 4
Capital Rx, Inc.: Raise no. 3, Apr 2021 × Investors in this round 4 investors had bought by the notice of Jul 14, 2021: 4 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $3 M of $3 M offered
Smallest investment taken no minimum stated
What was sold options or other rights to buy securities Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice A. J. Loiacono · Executive Officer, Director Joseph J. Alexander · Executive Officer, Director Laleh J. Alemzadeh · Executive Officer · Secretary Jared J. Kesselheim · Director Kevin J. Hill · Director Lenard J. Marcus · Director Ryan J. Kelly · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by A.J. Loiacono, Ceo. Source: SEC Form D, newest notice filed Jul 14, 2021. Read the notice at the SEC .
options SEC Dec 2020 $32 M No. 2 $10 to $50 million 4
Capital Rx, Inc.: Raise no. 2, Dec 2020 × Investors in this round 4 investors had bought by the notice of Jan 5, 2021: 4 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $32 M of $53 M offered; $21 M still to sell
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice A. J. Loiacono · Executive Officer, Director Joseph J. Alexander · Executive Officer, Director Laura J. Alemzadeh · Executive Officer · Secretary Jared J. Kesselheim · Director Kevin J. Hill · Director Lenard J. Marcus · Director Ryan J. Kelly · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the amounts: “Total offering amount consists of an initial closing of $31,960,627.84 and a milestone sale of $3,499,998.47 and up to an additional $17,539,367.40 at one or more subsequent closings with a right to purchase any remaining amount not sold.”Signed by A.J. Loiacono, Ceo. Source: SEC Form D, newest notice filed Jan 5, 2021. Read the notice at the SEC .
equity SEC Jul 2019 $12 M No. 1 $10 to $50 million 1
Capital Rx, Inc.: Raise no. 1, Jul 2019 × Investors in this round 1 investor had bought by the notice of Jul 19, 2019: 1 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $12 M of $16 M offered; $4 M still to sell
Smallest investment taken $16,382,777
What was sold equity, options or other rights to buy securities Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice A.J. Loiacono · Executive Officer, Director Joseph Alexander · Director Lenard Marcus · Director Ryan Kelly · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the amounts: “Total offering amount consists of $12,382,779.89 of equity securities and a warrant to purchase up to an additional $3,999,997.41 of equity securities.”Signed by A.J. Loiacono, Ceo. Source: SEC Form D, newest notice filed Jul 19, 2019. Read the notice at the SEC .
equity, options SEC